nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—Otitis—Octreotide—thymus cancer	0.0778	0.0971	CcSEcCtD
Triamcinolone—BCHE—diaphragm—thymus cancer	0.0599	0.302	CbGeAlD
Triamcinolone—Glucose tolerance impaired—Octreotide—thymus cancer	0.0501	0.0625	CcSEcCtD
Triamcinolone—Osteonecrosis—Octreotide—thymus cancer	0.0362	0.0452	CcSEcCtD
Triamcinolone—Ear infection—Octreotide—thymus cancer	0.0317	0.0396	CcSEcCtD
Triamcinolone—Intraocular pressure increased—Octreotide—thymus cancer	0.0307	0.0383	CcSEcCtD
Triamcinolone—Trauma—Octreotide—thymus cancer	0.0283	0.0354	CcSEcCtD
Triamcinolone—Peptic ulcer—Octreotide—thymus cancer	0.0202	0.0252	CcSEcCtD
Triamcinolone—Throat sore—Octreotide—thymus cancer	0.0187	0.0234	CcSEcCtD
Triamcinolone—Oropharyngeal discomfort—Octreotide—thymus cancer	0.0186	0.0232	CcSEcCtD
Triamcinolone—Neuritis—Octreotide—thymus cancer	0.0181	0.0226	CcSEcCtD
Triamcinolone—Stinging—Octreotide—thymus cancer	0.0167	0.0208	CcSEcCtD
Triamcinolone—Petechiae—Octreotide—thymus cancer	0.0164	0.0205	CcSEcCtD
Triamcinolone—Acne—Octreotide—thymus cancer	0.016	0.02	CcSEcCtD
Triamcinolone—Arthropathy—Octreotide—thymus cancer	0.0148	0.0185	CcSEcCtD
Triamcinolone—Oropharyngeal pain—Octreotide—thymus cancer	0.0148	0.0185	CcSEcCtD
Triamcinolone—Wheezing—Octreotide—thymus cancer	0.0131	0.0164	CcSEcCtD
Triamcinolone—Candida infection—Octreotide—thymus cancer	0.0129	0.0161	CcSEcCtD
Triamcinolone—SERPINA6—hematopoietic system—thymus cancer	0.0127	0.064	CbGeAlD
Triamcinolone—Neuropathy—Octreotide—thymus cancer	0.0127	0.0158	CcSEcCtD
Triamcinolone—Thrombophlebitis—Octreotide—thymus cancer	0.0113	0.0141	CcSEcCtD
Triamcinolone—Diabetes mellitus—Octreotide—thymus cancer	0.0113	0.0141	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Octreotide—thymus cancer	0.0108	0.0135	CcSEcCtD
Triamcinolone—Injury—Octreotide—thymus cancer	0.0107	0.0133	CcSEcCtD
Triamcinolone—Anaphylactoid reaction—Octreotide—thymus cancer	0.0101	0.0126	CcSEcCtD
Triamcinolone—Osteoarthritis—Octreotide—thymus cancer	0.0098	0.0122	CcSEcCtD
Triamcinolone—SERPINA6—pituitary gland—thymus cancer	0.00943	0.0475	CbGeAlD
Triamcinolone—Muscular weakness—Octreotide—thymus cancer	0.00864	0.0108	CcSEcCtD
Triamcinolone—Abdominal distension—Octreotide—thymus cancer	0.00852	0.0106	CcSEcCtD
Triamcinolone—Influenza—Octreotide—thymus cancer	0.00847	0.0106	CcSEcCtD
Triamcinolone—Asthma—Octreotide—thymus cancer	0.00847	0.0106	CcSEcCtD
Triamcinolone—Pancreatitis—Octreotide—thymus cancer	0.0083	0.0104	CcSEcCtD
Triamcinolone—Sweating increased—Octreotide—thymus cancer	0.00825	0.0103	CcSEcCtD
Triamcinolone—SERPINA6—bone marrow—thymus cancer	0.00815	0.041	CbGeAlD
Triamcinolone—Bronchitis—Octreotide—thymus cancer	0.00814	0.0102	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Octreotide—thymus cancer	0.00787	0.00982	CcSEcCtD
Triamcinolone—Weight increased—Octreotide—thymus cancer	0.0077	0.00961	CcSEcCtD
Triamcinolone—NR3C1—neck—thymus cancer	0.00748	0.0377	CbGeAlD
Triamcinolone—Neuropathy peripheral—Octreotide—thymus cancer	0.0074	0.00923	CcSEcCtD
Triamcinolone—SERPINA6—lung—thymus cancer	0.00738	0.0372	CbGeAlD
Triamcinolone—Conjunctivitis—Octreotide—thymus cancer	0.00734	0.00915	CcSEcCtD
Triamcinolone—Epistaxis—Octreotide—thymus cancer	0.00712	0.00888	CcSEcCtD
Triamcinolone—Bradycardia—Octreotide—thymus cancer	0.0069	0.00861	CcSEcCtD
Triamcinolone—Rhinitis—Octreotide—thymus cancer	0.00679	0.00848	CcSEcCtD
Triamcinolone—Pharyngitis—Octreotide—thymus cancer	0.00673	0.00839	CcSEcCtD
Triamcinolone—BCHE—hematopoietic system—thymus cancer	0.00625	0.0315	CbGeAlD
Triamcinolone—Arrhythmia—Octreotide—thymus cancer	0.00605	0.00755	CcSEcCtD
Triamcinolone—Erythema—Octreotide—thymus cancer	0.0059	0.00736	CcSEcCtD
Triamcinolone—Back pain—Octreotide—thymus cancer	0.00571	0.00712	CcSEcCtD
Triamcinolone—NR3C1—hematopoietic system—thymus cancer	0.00557	0.028	CbGeAlD
Triamcinolone—Ill-defined disorder—Octreotide—thymus cancer	0.00547	0.00683	CcSEcCtD
Triamcinolone—Malaise—Octreotide—thymus cancer	0.00532	0.00664	CcSEcCtD
Triamcinolone—Vertigo—Octreotide—thymus cancer	0.0053	0.00661	CcSEcCtD
Triamcinolone—Syncope—Octreotide—thymus cancer	0.00529	0.0066	CcSEcCtD
Triamcinolone—Loss of consciousness—Octreotide—thymus cancer	0.00518	0.00647	CcSEcCtD
Triamcinolone—Cough—Octreotide—thymus cancer	0.00515	0.00642	CcSEcCtD
Triamcinolone—Convulsion—Octreotide—thymus cancer	0.00511	0.00638	CcSEcCtD
Triamcinolone—Hypertension—Octreotide—thymus cancer	0.00509	0.00635	CcSEcCtD
Triamcinolone—NR3C1—epithelium—thymus cancer	0.00509	0.0256	CbGeAlD
Triamcinolone—Myalgia—Octreotide—thymus cancer	0.00502	0.00627	CcSEcCtD
Triamcinolone—Discomfort—Octreotide—thymus cancer	0.00496	0.00619	CcSEcCtD
Triamcinolone—Dry mouth—Octreotide—thymus cancer	0.00491	0.00613	CcSEcCtD
Triamcinolone—PTGS2—hematopoietic system—thymus cancer	0.00482	0.0243	CbGeAlD
Triamcinolone—Anaphylactic shock—Octreotide—thymus cancer	0.00481	0.00601	CcSEcCtD
Triamcinolone—Oedema—Octreotide—thymus cancer	0.00481	0.00601	CcSEcCtD
Triamcinolone—Infection—Octreotide—thymus cancer	0.00478	0.00597	CcSEcCtD
Triamcinolone—BCHE—cardiac atrium—thymus cancer	0.00475	0.0239	CbGeAlD
Triamcinolone—Shock—Octreotide—thymus cancer	0.00474	0.00591	CcSEcCtD
Triamcinolone—Tachycardia—Octreotide—thymus cancer	0.0047	0.00586	CcSEcCtD
Triamcinolone—Hyperhidrosis—Octreotide—thymus cancer	0.00465	0.00581	CcSEcCtD
Triamcinolone—BCHE—pituitary gland—thymus cancer	0.00464	0.0234	CbGeAlD
Triamcinolone—PTGS2—epithelium—thymus cancer	0.0044	0.0222	CbGeAlD
Triamcinolone—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00439	0.00547	CcSEcCtD
Triamcinolone—Insomnia—Octreotide—thymus cancer	0.00435	0.00543	CcSEcCtD
Triamcinolone—Paraesthesia—Octreotide—thymus cancer	0.00432	0.00539	CcSEcCtD
Triamcinolone—Dyspnoea—Octreotide—thymus cancer	0.00429	0.00536	CcSEcCtD
Triamcinolone—Dyspepsia—Octreotide—thymus cancer	0.00424	0.00529	CcSEcCtD
Triamcinolone—NR3C1—cardiac atrium—thymus cancer	0.00423	0.0213	CbGeAlD
Triamcinolone—CYP3A4—hematopoietic system—thymus cancer	0.00421	0.0212	CbGeAlD
Triamcinolone—Fatigue—Octreotide—thymus cancer	0.00415	0.00518	CcSEcCtD
Triamcinolone—NR3C1—pituitary gland—thymus cancer	0.00413	0.0208	CbGeAlD
Triamcinolone—Pain—Octreotide—thymus cancer	0.00412	0.00514	CcSEcCtD
Triamcinolone—BCHE—bone marrow—thymus cancer	0.00401	0.0202	CbGeAlD
Triamcinolone—BCHE—thyroid gland—thymus cancer	0.004	0.0201	CbGeAlD
Triamcinolone—Feeling abnormal—Octreotide—thymus cancer	0.00397	0.00495	CcSEcCtD
Triamcinolone—NR3C1—lymphoid tissue—thymus cancer	0.00392	0.0197	CbGeAlD
Triamcinolone—Urticaria—Octreotide—thymus cancer	0.00382	0.00477	CcSEcCtD
Triamcinolone—Body temperature increased—Octreotide—thymus cancer	0.00381	0.00475	CcSEcCtD
Triamcinolone—BCHE—lung—thymus cancer	0.00363	0.0183	CbGeAlD
Triamcinolone—PTGS2—pituitary gland—thymus cancer	0.00357	0.018	CbGeAlD
Triamcinolone—NR3C1—bone marrow—thymus cancer	0.00357	0.018	CbGeAlD
Triamcinolone—NR3C1—thyroid gland—thymus cancer	0.00356	0.0179	CbGeAlD
Triamcinolone—Hypersensitivity—Octreotide—thymus cancer	0.00355	0.00443	CcSEcCtD
Triamcinolone—Asthenia—Octreotide—thymus cancer	0.00345	0.00431	CcSEcCtD
Triamcinolone—Pruritus—Octreotide—thymus cancer	0.00341	0.00425	CcSEcCtD
Triamcinolone—PTGS2—lymphoid tissue—thymus cancer	0.00339	0.0171	CbGeAlD
Triamcinolone—NR3C1—lung—thymus cancer	0.00323	0.0163	CbGeAlD
Triamcinolone—Dizziness—Octreotide—thymus cancer	0.00318	0.00397	CcSEcCtD
Triamcinolone—PTGS2—bone marrow—thymus cancer	0.00309	0.0156	CbGeAlD
Triamcinolone—Vomiting—Octreotide—thymus cancer	0.00306	0.00382	CcSEcCtD
Triamcinolone—Rash—Octreotide—thymus cancer	0.00304	0.00379	CcSEcCtD
Triamcinolone—Dermatitis—Octreotide—thymus cancer	0.00303	0.00378	CcSEcCtD
Triamcinolone—Headache—Octreotide—thymus cancer	0.00302	0.00376	CcSEcCtD
Triamcinolone—Nausea—Octreotide—thymus cancer	0.00286	0.00357	CcSEcCtD
Triamcinolone—PTGS2—lung—thymus cancer	0.0028	0.0141	CbGeAlD
Triamcinolone—BCHE—lymph node—thymus cancer	0.00248	0.0125	CbGeAlD
Triamcinolone—NR3C1—lymph node—thymus cancer	0.00221	0.0111	CbGeAlD
Triamcinolone—PTGS2—lymph node—thymus cancer	0.00191	0.00964	CbGeAlD
